Registry for headache and vertigo conditions in China
China Headache and Vertigo Registry Study
This study is collecting information from people of all ages who have headaches or vertigo to see how different treatments work and how these conditions relate to other health issues.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 4 Years to 99 Years |
| Sex | All |
| Sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University Academic / other |
| Locations | 1 site (Hangzhou, Zhejiang) |
| Trial ID | NCT04939922 on ClinicalTrials.gov |
What this trial studies
The China Headache Registry Study collects data from patients aged 4 to 99 years who suffer from various headache disorders, including migraines and tension-type headaches, as well as vertigo and chronic pain conditions. The study aims to investigate biomarkers, imaging features, genetic characteristics, and treatment outcomes related to these conditions. Participants will be followed long-term to assess the effectiveness of treatments and the relationship of headaches with other diseases. The study adheres to Good Clinical Practice (GCP) guidelines to ensure data integrity and participant safety.
Who should consider this trial
Good fit: Ideal candidates include individuals aged 4 to 99 years diagnosed with primary or secondary headache disorders according to ICHD-3 criteria.
Not a fit: Patients who are unable to complete headache diaries or who cannot commit to long-term follow-up may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and management of headache and vertigo disorders, ultimately enhancing patient care.
How similar studies have performed: While similar observational studies have been conducted, this specific registry approach focusing on a comprehensive range of headache and vertigo conditions is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Written informed consent and participant privacy information (eg, Written Authorization for Use and Release of Health and Research Study Information) obtained from the participant prior to initiation of any study-specific procedures. * Male or female participants ages 4 to 99 years. * Headache patients meeting the diagnostic criteria for ICHD-3, including primary headaches such as migraine and tension tension-type headaches, secondary headaches. * Patients who meet the headache diagnosis in the ICHD-3 appendix (including vestibular migraine). Exclusion Criteria: * Patients who were unable to complete scales such as headache diary. * Patients denied or unable to be admitted for long-term follow-up.
Where this trial is running
Hangzhou, Zhejiang
- Kaiming Liu — Hangzhou, Zhejiang, China (Recruiting)
Study contacts
- Principal investigator: Kaiming Liu, Doctor — headache specialist clinic of the Second Affiliated Hospital of Zhejiang Medical University
- Study coordinator: Kaiming Liu, Doctor
- Email: 2314411@zju.edu.cn
- Phone: +8615068862055
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.